Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis Identifies Ameloblastin-Related Competitive Endogenous RNA as a Prognostic Biomarker for Testicular Germ Cell Tumour. | Cancers (Basel) | 2022 | 35454778 | PubTator, text mining | PubMed |
| A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. | Cancer Cell | 2022 | 35452604 | PubTator, text mining | PubMed |
| LINC00174 Suppresses Non-Small Cell Lung Cancer Progression by Up-Regulating LATS2 via Sponging miR-31-5p. | Cell J | 2022 | 35451584 | PubTator, text mining | PubMed |
| The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021. | J Transl Med | 2022 | 35449104 | PubTator, text mining | PubMed |
| Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. | Front Pharmacol | 2022 | 35444536 | PubTator, text mining | PubMed |
| Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer. | Front Oncol | 2022 | 35433433 | PubTator, text mining | PubMed |
| Novel Immunotherapies for Osteosarcoma. | Front Oncol | 2022 | 35433427 | PubTator, text mining | PubMed |
| Emerging Strategies in TCR-Engineered T Cells. | Front Immunol | 2022 | 35432319 | PubTator, text mining | PubMed |
| Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development. | Front Oncol | 2022 | 35419278 | PubTator, text mining | PubMed |
| Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function. | Cancer Cell | 2022 | 35413271 | PubTator, text mining | PubMed |
| Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer? | Cells | 2022 | 35406791 | PubTator, text mining | PubMed |
| Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy. | Cancers (Basel) | 2022 | 35406441 | PubTator, text mining | PubMed |
| Using a Gene Network of Pyroptosis to Quantify the Responses to Immunotherapy and Prognosis for Neuroblastoma Patients. | Front Immunol | 2022 | 35401536 | PubTator, text mining | PubMed |
| Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis. | Gynecol Oncol | 2022 | 35400527 | PubTator, text mining | PubMed |
| Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. | Nat Rev Cancer | 2022 | 35393541 | PubTator, text mining | PubMed |
| Tuning T cell receptor sensitivity through catch bond engineering. | Science | 2022 | 35389803 | PubTator, text mining | PubMed |
| Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. | Signal Transduct Target Ther | 2022 | 35387984 | PubTator, text mining | PubMed |
| Pinpointing the tumor-specific T cells via TCR clusters. | Elife | 2022 | 35377314 | PubTator, text mining | PubMed |
| Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types. | Front Cell Dev Biol | 2022 | 35372330 | PubTator, text mining | PubMed |
| Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges. | Front Oncol | 2022 | 35356211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=29